New Approach Which Can Help To Predict Neurodegenerative DiseasesNew investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America...
New Way To Grow Adult Stem Cells In Culture May Lead To Treatment For Muscular DystrophyResearchers at the Stanford University School of Medicine have developed a technique they believe will help scientists overcome a major hurdle to the use of adult stem cells for treating muscular dystrophy and other muscle-wasting disorders that accompany aging or disease: They've found that growing muscle stem cells on a specially developed synthetic matrix that mimics the ela...
Shining A Spotlight On Lou Gehrig's DiseaseLocal scientists, health advocates and leaders from the California Institute for Regenerative Medicine (CIRM) will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The meeting, to be held at 8:30 a.m...
Start Of New Therapy For Late-Onset Pompe Patients In USThe first commercially available treatment in the United States for patients with late-onset Pompe disease was administered June 16 at the University of Florida. Pompe disease is a rare form of muscular dystrophy and has been the focus of a research program at UF for more than 10 years. It is now part of expanded efforts in neuromuscular disease research...
Progression Of ALS May Be Slowed By ExerciseUniversity of Alberta researchers are looking at exercise as a new way to slow the degenerative processes of ALS, commonly known as Lou Gehrig's disease. Dr. Kelvin Jones, a recipient of this year's ALS Canada Discovery Grant, has been pioneering research in this field for four years, using mice genetically altered to present familial ALS...
News From The American Journal Of PathologyInflammasome Increases Muscle Damage in Muscular Dystrophy Dr. Kanneboyina Nagaraju and colleagues at the Children's National Medical Center, Washington, DC demonstrate that affected muscle may directly contribute to inflammation in muscular dystrophy. Their report can be found in the June 2010 issue of The American Journal of Pathology...
Neuralstem Updates Clinical Trial ProgressNeuralstem, Inc. (NYSE Amex: CUR) updated the progress of its ongoing Phase I human clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia...
Stem Cells To Unlock Secrets Of Motor Neurone DiseaseBeing able to grow and program human motor neurones in the lab has been the dream motor neurone disease scientists for several years. The Motor Neurone Disease (MND) Association is funding its first ever stem cell research program with the aim of finding the secrets of this neurological condition. Spelling - Motor Neurone Disease or Motor Neuron Disease are both possible spellings...
Galapagos Initiates Clinical Studies With GLPG0492, A Candidate Drug For CachexiaGalapagos NV (Euronext: GLPG) announced that it has initiated a first-in-human trial for GLPG0492, its candidate drug for cachexia (loss of weight and muscle mass) and potentially other indications, such as Duchenne muscular dystrophy. GLPG0492 is an orally available small molecule that Galapagos has developed in its Selective Androgen Receptor Modulator (SARM) program...
![](\"http://www.igotyourindex.com/igyindex.gif?DOCUMENTNAME=&DOCUMENTLINK=&GOALNAME&=DOCUMENTVALUE&=GROUPNAME\")